Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Roivant Sciences, Raises Price Target to $8

SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $7 to $8.
byBenzinga Newsdesk
November 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $7 to $8.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Precision Drilling Shares Are Rocketing Today: What’s Going On?

By Lekha Gupta
February 6, 1:18 PM
Precision Drilling sees a surge in shares as Q4 results reveal C$506.9 million in revenues, driven by increased North American and international activity, with adjusted EBITDA hitting C$151.2 million. CEO Kevin Neveu outlines a bullish outlook, anticipating a 40% Y/Y increase in international rig count, driven by term contracts in Kuwait and Saudi Arabia. The company aims to reduce debt and allocate significant portions of free cash flow to share repurchases.

PDS